TABLE 2.

Clinical trials using angiotensin‐(1–7) in the treatment of COVID‐19

Study	Registry identifier	Title	Interventions
1	NCT04401423	TXA127 for the treatment of severe COVID‐19	Intravenous angiotensin‐(1–7) (TXA127)
2	NCT04332666	Angiotensin‐(1, 7) treatment in COVID‐19: the ATCO Trial (ATCO)	Intravenous angiotensin‐(1–7) infusion
3	NCT04570501	Angiotensin‐(1–7) for the treatment of COVID‐19 in hospitalized patients	Intravenous angiotensin‐(1–7) infusion
4	NCT04633772	Use of angiotensin‐(1–7) in COVID‐19	Intravenous supplementation of angiotensin‐(1–7)
5	NCT04375124	Treatment of angiotensin peptide (1–7) for COVID‐19	Angiotensin‐(1–7) derived plasma
6	NCT04605887	Angiotensin 1–7 as a therapy in the treatment of COVID‐19	Subcutaneous angiotensin‐ (1–7)